| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3913669 | Contraception | 2013 | 5 Pages |
Abstract
The high prevalence of dyslipidemia could justify lipid profile evaluation before prescribing a COC. BMI and smoking represent modest predictive markers for the presence of dyslipidemia in candidates for the use of combined oral contraceptives.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Rogério Bonassi Machado, Carine Rejane Bernardes, Isadora Matias de Souza, Narayana Santana, Mariana Morimoto,